Table 2.
TCR T cells | TCR-tCD34 T cells | ||||
---|---|---|---|---|---|
T | P | S | S | CD34 | |
T cell output numbers (directly after MACS)b | ± | – | + | + | ++ |
T cell yield (1 week after MACS)c | ± | – | + | ± | ++ |
T cell expansion (1 week after MACS)d | ± | ± | ++ | – | ++ |
T cell expansion (3–6 weeks after MACS)d | ± | + | + | + | ++ |
pMHC binding (1 week after MACS)e | + | + | ++ | + | – |
pMHC binding (3–6 weeks after MACS)e | + | – | ++ | ± | – |
tCD34 expression (1 week after MACS)f | NA | NA | NA | ++ | ++ |
tCD34 expression (3–6 weeks after MACS)f | NA | NA | NA | ++ | ++ |
Antigen-specific CD107a mobilizationg | ND | ND | ± | ± | ++ |
Antigen-specific IFN-γ secretionh | ND | ND | ± | ± | ++ |
Primary human T cell populations were transduced with TCR or TCR-tCD34 genes, MACSorted with gp100/A2 tetramers (T), pentamers (P), or Streptamers (S), or with CD34 mAb (CD34), and evaluated for various in vitro parameters. See Materials and Methods for details.
T cell numbers directly after MACS (counted microscopically): –, 0–0.10×106:±, 0.10–0.25×106;+, 0.26–0.75×106; ++, >0.75×106.
T cell numbers 1 week after MACS (counted microscopically): –, 0–1×106;±, 2–5×106; +, 6–15×106; ++, >15×106.
T cell expansion 1 or 3–6 week(s) after MACS (fold increase in T cell numbers at 1 week vs. directly after MACS and 3–6 weeks vs. 1 week after MACS, respectively): –, 0–10;±, 11–15;+, 16–20; ++, >20.
Peptide–MHC binding 1 and 3–6 week(s) after MACS (measured by flow cytometry with gp100/A2 pentamer): –, ≤20% (value before MACS);±, 21–30; +, 31–50; ++, >50%.
tCD34 expression 1 and 3–6 week(s) after MACS (measured by flow cytometry with CD34 mAb):–, ≤70% (value before MACS);±, 71–80; +, 81–90; ++, >90%.
T cell CD107a mobilization 3–6 weeks after MACS (measured by flow cytometry with CD107a mAb on peptide-specific stimulation): –, 0–20;±, 21–40; +, 41–60; ++, >60%.
T cell IFN-γ production 3–6 weeks after MACS (measured by ELISA on peptide-specific stimulation): –, 0–5;±, 6–10; +, 11–20; ++, >20 ng/ml.
MACS, magnetic-activated cell sorting; NA, not applicable; ND, not determined; pMHC, peptide–MHC; tCD34, truncated CD34.